MedTrace Logo

AF Stroke Substudy SL-ECG Versus 12lead ECG

NCT03715361 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2020-03-10

No results posted yet for this study

Summary

The purpose of the study is to compare parameters obtained per SL-ECG with the values from 12lead-ECG measurement. Patients who undergo out- or inpatient treatment and who receive a 12lead-ECG are asked to participate in this examination. Furthermore, 50 patients without heart disease should be included (control group).

Conditions

Interventions

DIAGNOSTIC_TEST

SL-ECG

additional SL-ECG measurement

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Nikolaus Marx · Head of the Clinic for Cardiology, Pneumology, Angiology and Internal Intensive Medicine

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-09
Primary Completion
2019-03-26
Completion
2019-03-26

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03715361 on ClinicalTrials.gov